Maple Capital Management, Inc. - ENZO BIOCHEM INC ownership

ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 112 filers reported holding ENZO BIOCHEM INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Maple Capital Management, Inc. ownership history of ENZO BIOCHEM INC
ValueSharesWeighting
Q1 2017$117,000
+20.6%
14,0000.0%0.04%
+16.7%
Q4 2016$97,000
+36.6%
14,0000.0%0.03%
+30.4%
Q3 2016$71,000
-15.5%
14,0000.0%0.02%
-25.8%
Q2 2016$84,000
+31.2%
14,0000.0%0.03%
+29.2%
Q1 2016$64,000
+1.6%
14,0000.0%0.02%
+9.1%
Q4 2015$63,000
+43.2%
14,0000.0%0.02%
+37.5%
Q3 2015$44,000
+4.8%
14,0000.0%0.02%
+14.3%
Q2 2015$42,000
+2.4%
14,0000.0%0.01%0.0%
Q1 2015$41,000
-33.9%
14,0000.0%0.01%
-36.4%
Q4 2014$62,00014,0000.02%
Other shareholders
ENZO BIOCHEM INC shareholders Q3 2016
NameSharesValueWeighting ↓
Evermore Global Advisors, LLC 3,555,233$39,250,0009.97%
CORRADO ADVISORS, LLC 326,101$3,600,0001.97%
KOPP INVESTMENT ADVISORS LLC 199,132$2,198,0001.97%
First Light Asset Management, LLC 403,082$4,450,0001.49%
Millrace Asset Group, Inc. 115,878$1,279,0001.21%
KEMPNER CAPITAL MANAGEMENT INC. 95,476$1,054,0000.69%
MARATHON CAPITAL MANAGEMENT 115,000$1,270,0000.60%
Campbell & CO Investment Adviser LLC 33,513$370,0000.34%
EAM Investors, LLC 159,930$1,766,0000.29%
ABNER HERRMAN & BROCK LLC 100,000$1,104,0000.21%
View complete list of ENZO BIOCHEM INC shareholders